⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMRX News
Amneal Pharmaceuticals, Inc. Class A Common Stock
Procyon Corporation Announces the Results of the Special Meeting of Shareholders
businesswire.com
AMRX
Emvolon Raises $22 million Funding Round to Launch its Modular, Waste-to-Fuel Chemical Plants
globenewswire.com
AMRX
Form 8-K/A
sec.gov
AMRX
Amneal to Report Third Quarter 2026 Results on November 3, 2026
globenewswire.com
AMRX
Amneal Announces FDA Approval and Launch of Lanreotide Injection
globenewswire.com
AMRX
Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
globenewswire.com
AMRX
Biosimilars Market worth $70.79 billion by 2036 - Exclusive Report by MarketsandMarkets™
prnewswire.com
PFE
AMGN
AMRX
Global Peptide Synthesis Market Outlook Report 2026-2035 | Set to Reach USD 7 Billion by 2035, Driven by GLP-1 Demand and Manufacturing Capacity Expansion
globenewswire.com
VKTX
AMRX
Zambon gibt EU-Zulassung für Hopledo® zur Behandlung moderater bis schwerer motorischer Fluktuationen bei Erwachsenen mit Parkinson bekannt
businesswire.com
AMRX
Zambon annuncia l’approvazione da parte della Commissione Europea di Hopledo® per pazienti adulti con Malattia di Parkinson e fluttuazioni motorie da moderate a severe
businesswire.com
AMRX